Viviana Pensato

Viviana Pensato

Auto-generated profile, based on publicly available information

Viviana Pensato

Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Neuron
Verified
Journal Article
Closed access
ANAude Nicolas
Aude Nicolas
KKKevin P. Kenna
Kevin P. Kenna
ARAlan E. Renton
Alan E. Renton
NTNicola Ticozzi
Nicola Ticozzi
FFFaraz Faghri
Faraz Faghri
NTNatalie A. Twine
Natalie A. Twine

25 July 2016 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
PRParals Registry
Parals Registry
WRWouter van Rheenen
Wouter van Rheenen
SGSLALOM Group
SLALOM Group
SRSlap Registry
Slap Registry
FCFALS Sequencing Consortium
FALS Sequencing Consortium
JVJan H Veldink
Jan H Veldink

1 October 2014 in Neuron
Verified
Journal Article
Closed access
BSBradley N. Smith
Bradley N. Smith
NTNicola Ticozzi
Nicola Ticozzi
CFClaudia Fallini
Claudia Fallini
AGAthina Soragia Gkazi
Athina Soragia Gkazi
STSimon Topp
Simon Topp
CBCinzia Bertolin
Cinzia Bertolin

15 May 2014 in Brain
Verified
Journal Article
Closed access
PDF file
VPViviana Pensato
Viviana Pensato
BCBARBARA CASTELLOTTI
BARBARA CASTELLOTTI
CGCinzia Gellera
Cinzia Gellera
DPDavide Pareyson
Davide Pareyson
CCClaudia Ciano
Claudia Ciano
CMCaterina Mariotti
Caterina Mariotti
Hereditary spastic paraplegias are a heterogeneous group of neurodegenerative disorders, clinically classified in pure and complex forms. Genetically, more than 70 different forms of spastic paraplegias have been characterized. A subgroup of complicate recessive forms has been distinguished for the presence of thin corpus callosum and white matter lesions at brain imaging. This group includes several genetic entities, but most of the cases are caused by mutations in the KIAA1840 (SPG11) and ZFYVE26 genes (SPG15). We studied a cohort of 61 consecutive patients with complicated spastic paraplegias, presenting at least one of the following features: mental retardation, thin corpus callosum and/or white matter lesions. DNA samples were screened for mutations in the SPG11 /KIAA1840, SPG15/ ZFYVE26, SPG21 /ACP33 , SPG35 /FA2H , SPG48 /AP5Z1 and SPG54 /DDHD2 genes by direct sequencing. Sequence variants were found in 30 of 61 cases: 16 patients carried SPG11/ KIAA1840 gene variants (26.2%), nine patients carried SPG15 /ZFYVE26 variants (14.8%), three patients SPG35 /FA2H (5%), and two patients carried SPG48/ AP5Z1 gene variants (3%). Mean age at onset was similar in patients with SPG11 and with SPG15 (range 11–36), and the phenotype was mostly indistinguishable. Extrapyramidal signs were observed only in patients with SPG15, and epilepsy in three subjects with SPG11. Motor axonal neuropathy was found in 60% of cases with SPG11 and 70% of cases with SPG15. Subjects with SPG35 had intellectual impairment, spastic paraplegia, thin corpus callosum, white matter hyperintensities, and cerebellar atrophy. Two families had a late-onset presentation, and none had signs of brain iron accumulation. The patients with SPG48 were a 5-year-old child, homozygous for a missense SPG48/ AP5Z1 variant, and a 51-year-old female, carrying two different nonsense variants. Both patients had intellectual deficits, thin corpus callosum and white matter lesions. None of the cases in our cohort carried mutations in the SPG21 /ACP33 and SPG54/ DDH2H genes. Our study confirms that the phenotype of patients with SPG11 and with SPG15 is homogeneous, whereas cases with SPG35 and with SPG48 cases present overlapping features, and a broader clinical spectrum. The large group of non-diagnosed subjects (51%) suggests further genetic heterogeneity. The observation of common clinical features in association with defects in different causative genes, suggest a general vulnerability of the corticospinal tract axons to a wide spectrum of cellular alterations. * Abbreviations : ALS : amyotrophic lateral sclerosis SNP : single nucleotide polymorphism SPG : spastic paraplegia

26 October 2009 in Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
LCLucia Corrado
Lucia Corrado
RBRoberto Del Bo
Roberto Del Bo
BCBARBARA CASTELLOTTI
BARBARA CASTELLOTTI
ARAntonia Ratti
Antonia Ratti
CCCristina Cereda
Cristina Cereda
VSVincenzo Silani
Vincenzo Silani
Background: Mutations in the FUS gene have recently been discovered to be a major cause of familial amyotrophic lateral sclerosis (FALS). Objective: To determine the identity and frequency of FUS gene mutations in a large cohort of Italian patients enriched in sporadic cases (SALS). Methods: Exons 5, 6, 14 and 15 of the FUS gene were screened for mutations in 1009 patients (45 FALS and 964 SALS). The genetic analysis was extended to the entire coding sequence of FUS in all the FALS and 293 of the SALS patients. Results: Seven missense mutations (p.G191S, p.R216C, p.G225V, p.G230C, p.R234C, p.G507D and p.R521C) were identified in nine patients (seven SALS and two FALS), and none in 500 healthy Italian controls. All mutations are novel except for the p.R521C mutation identified in one SALS and one FALS case. Both patients showed a similar unusual presentation, with proximal, mostly symmetrical, upper limb weakness, with neck and axial involvement. With the exception of p.G507D and p.R521C, the mutations identified in SALS patients are all localised in the glycine-rich region encoded by exon 6. In addition, eight different in-frame deletions in two polyglycine motifs were detected, the frequency of which was not significantly different in patients and controls. Conclusions: The results show that FUS missense mutations are present in 0.7% of Italian SALS cases, and confirm the previous mutational frequency reported in FALS (4.4%). An unusual proximal and axial clinical presentation seems to be associated with the presence of the p.R521C mutation.

20 November 2013 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
IFIsabella Fogh
Isabella Fogh
ARAntonia Ratti
Antonia Ratti
CGCinzia Gellera
Cinzia Gellera
KLKuang Lin
Kuang Lin
CTCinzia Tiloca
Cinzia Tiloca
JZJ. G. Zheng
J. G. Zheng
Identification of mutations at familial loci for amyotrophic lateral sclerosis (ALS) has provided novel insights into the aetiology of this rapidly progressing fatal neurodegenerative disease. However, genome-wide association studies (GWAS) of the more common (∼90%) sporadic form have been less successful with the exception of the replicated locus at 9p21.2. To identify new loci associated with disease susceptibility, we have established the largest association study in ALS to date and undertaken a GWAS meta-analytical study combining 3959 newly genotyped Italian individuals (1982 cases and 1977 controls) collected by SLAGEN (Italian Consortium for the Genetics of ALS) together with samples from Netherlands, USA, UK, Sweden, Belgium, France, Ireland and Italy collected by ALSGEN (the International Consortium on Amyotrophic Lateral Sclerosis Genetics). We analysed a total of 13 225 individuals, 6100 cases and 7125 controls for almost 7 million single-nucleotide polymorphisms (SNPs). We identified a novel locus with genome-wide significance at 17q11.2 (rs34517613 with P = 1.11 × 10−8; OR 0.82) that was validated when combined with genotype data from a replication cohort (P = 8.62 × 10−9; OR 0.833) of 4656 individuals. Furthermore, we confirmed the previously reported association at 9p21.2 (rs3849943 with P = 7.69 × 10−9; OR 1.16). Finally, we estimated the contribution of common variation to heritability of sporadic ALS as ∼12% using a linear mixed model accounting for all SNPs. Our results provide an insight into the genetic structure of sporadic ALS, confirming that common variation contributes to risk and that sufficiently powered studies can identify novel susceptibility loci.